MarketCap
Facebook
X
TelegramEyeGate Pharmaceuticals, Inc. P/S 2011-2026 | EYEG
P/S Jährlich EyeGate Pharmaceuticals, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 2.39 K | 6.8 | 10.5 | 38.5 | 23.6 | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 2.39 K | 6.8 | 495 |
P/S anderer Aktien in der Pharmaeinzelhändler
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
FSD Pharma
HUGE
|
172 | - | 5743.5 % | $ 69.7 M |  Canada |
 |
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M |  Germany |
 |
Happiness Biotech Group Limited
HAPP
|
0.429 | - | 1.35 % | $ 17.8 M |  China |
 |
AgeX Therapeutics
AGE
|
9.24 | - | -10.17 % | $ 12.2 K |  USA |
 |
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | USA |
 |
Genfit SA
GNFT
|
1.96 K | - | 2.54 % | $ 160 B |  France |
 |
AstraZeneca PLC
AZN
|
2.13 | - | - | $ 96.9 B |  Britain |
 |
Midatech Pharma plc
MTP
|
240 | - | -18.52 % | $ 27.3 M | Britain |
 |
Esperion Therapeutics
ESPR
|
1.39 | $ 3.12 | -0.32 % | $ 649 M | USA |
 |
Eton Pharmaceuticals
ETON
|
6.99 | $ 33.6 | -4.01 % | $ 904 M | USA |
 |
Forte Biosciences
FBRX
|
181 | $ 21.95 | -0.23 % | $ 284 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - |  Russia |
 |
Celyad Oncology SA
CYAD
|
21.3 K | - | - | $ 12.5 M |  Belgium |
 |
Berkeley Lights
BLI
|
1.49 | - | -7.31 % | $ 87 M | USA |
 |
Generation Bio Co.
GBIO
|
30.3 | - | - | $ 344 M | USA |
 |
IMV
IMV
|
48.2 | - | - | $ 13.1 M | Canada |
 |
BioNTech SE
BNTX
|
35.7 | $ 91.81 | 0.97 % | $ 22.2 B | Germany |
 |
Autolus Therapeutics plc
AUTL
|
4.27 | $ 1.72 | 4.24 % | $ 458 M | Britain |
 |
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M |  Israel |
 |
Grifols, S.A.
GRFS
|
0.627 | $ 8.01 | -1.29 % | $ 5.44 B |  Spain |
 |
Cyclacel Pharmaceuticals
CYCCP
|
2.54 | - | -4.36 % | $ 27 M | USA |
 |
Heron Therapeutics
HRTX
|
1.28 | $ 0.87 | -0.57 % | $ 145 M | USA |
 |
Compugen Ltd.
CGEN
|
2.7 | $ 2.74 | 4.98 % | $ 256 M | Israel |
 |
Anika Therapeutics
ANIK
|
1.9 | $ 14.91 | -0.77 % | $ 214 M | USA |
 |
Advaxis
ADXS
|
144 | - | -9.65 % | $ 45.9 M | USA |
 |
Aeterna Zentaris
AEZS
|
1.54 | - | 5.93 % | $ 314 M | Canada |
 |
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | USA |
 |
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | Germany |
 |
Applied Genetic Technologies Corporation
AGTC
|
41.6 | - | - | $ 26.5 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
11.9 | $ 3.42 | -0.58 % | $ 5.63 M | Israel |
 |
AIkido Pharma
AIKI
|
0.935 | - | 1.93 % | $ 17.4 M | USA |
 |
Aptinyx
APTX
|
204 | - | -39.0 % | $ 4.57 M | USA |
 |
Coherus BioSciences
CHRS
|
5.36 | $ 1.63 | 3.82 % | $ 191 M | USA |
 |
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
9.15 | $ 20.79 | -1.06 % | $ 2.65 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
236 | - | -11.43 % | $ 502 K | USA |